Search results

Skip to results

Area of interest

Area of interest

Type

Type

Status

Status

Last updated

Last updated

Guidance programme

Advice programme

Showing 4561 to 4575 of 8212 results

  1. NICE recommends further research to better inform future cost-effectiveness models of relapsing-remitting multiple sclerosis. In particular, this research should include a more comprehensive synthesis of available evidence on the underlying disease progression of multiple sclerosis in the UK context, the impact of disability and relapses on preference-based measures of quality of life, and associated resource use and costs.

    Recommendation ID TA320/1 Question NICE recommends further research to better inform future cost-effectiveness models of relapsing-remitting

    Research recommendation
    Published
    9 June 2015

  2. Morphine compared with ketamine for first-line management of pain:- Is morphine clinically and cost effective compared with ketamine for first-line pharmacological pain management (in both pre-hospital and hospital settings) in patients with major trauma?

    Recommendation ID NG39/3 Question Morphine compared with ketamine for first-line management of pain:- Is morphine clinically and cost effective

    Research recommendation
    Published
    21 March 2016

  3. Motivating dental practice teams to take a preventive approach:- What would motivate dental practice teams to take a preventive approach to oral health – especially with high risk groups – and how does this fit into the dental practice business model?

    Recommendation ID NG30/5 Question Motivating dental practice teams to take a preventive approach:- What would motivate dental practice

    Research recommendation
    Published
    28 January 2016

  4. MRI-guided laser interstitial thermal therapy for drug-resistant epilepsy Interventional procedures guidance

    Recommendation ID IPG671/1 Question MRI-guided laser interstitial thermal therapy for drug-resistant epilepsy Interventional procedures

    Research recommendation
    Published
    17 March 2020

  5. Mucoactive agents:- What is the most clinically and cost-effective dose of rhDNase (dornase alfa; recombinant human deoxyribonuclease) for people with cystic fibrosis?

    Recommendation ID NG78/6 Question Mucoactive agents:- What is the most clinically and cost-effective dose of rhDNase (dornase alfa; recombinant

    Research recommendation
    Published
    18 October 2018

  6. Multidimensional assessment of outcomes- How can the individual factors associated with COPD prognosis (collected from a range of sources including primary care, imaging and pulmonary rehabilitation results) be combined into a multidimensional analysis that provides accurate and useful information on prognosis?

    Recommendation ID NG115/2 Question Multidimensional assessment of outcomes- How can the individual factors associated with COPD prognosis

    Research recommendation
    Published
    6 February 2019

  7. Is the use of chlorhexidine body wash associated with increased antimicrobial resistance?

    Recommendation ID NG125/2 Question Is the use of chlorhexidine body wash associated with increased antimicrobial resistance? Any

    Research recommendation
    Published
    16 August 2019

  8. What is the clinical effectiveness of preoperative nasal decolonisation using mupirocin in combination with a chlorhexidine body wash in the whole population?

    Recommendation ID NG125/1 Question What is the clinical effectiveness of preoperative nasal decolonisation using mupirocin in combination

    Research recommendation
    Published
    16 August 2019

  9. What is the contribution to clinical effectiveness of the timing of nasal decolonisation and body wash for the prevention of surgical site infection?

    Recommendation ID NG125/6 Question What is the contribution to clinical effectiveness of the timing of nasal decolonisation and body wash

    Research recommendation
    Published
    26 October 2020

  10. Nasal suction:- What is the clinical and cost effectiveness of suction to remove secretions from the upper respiratory tract compared with minimal handling?

    Recommendation ID NG9/5 Question Nasal suction:- What is the clinical and cost effectiveness of suction to remove secretions from the upper

    Research recommendation
    Published
    6 October 2015

  11. National pre-hospital triage tool:- A national pre-hospital triage tool for major trauma should be developed and validated.

    Recommendation ID NG40/4 Question National pre-hospital triage tool:- A national pre-hospital triage tool for major trauma should be developed

    Research recommendation
    Published
    4 April 2016

  12. What is the natural history of post-COVID-19 syndrome?

    Recommendation ID NG188/5 Question What is the natural history of post-COVID-19 syndrome? Any explanatory notes(if applicable)

    Research recommendation
    Published
    12 November 2021

  13. Natural history of progression to colorectal cancer in people at increased risk:- What is the natural history of progression to colorectal cancer in people with inflammatory bowel disease (IBD) or adenomas?

    Recommendation ID CG118/2 Question Natural history of progression to colorectal cancer in people at increased risk:- What is the natural

    Research recommendation
    Published
    9 June 2015

  14. What is the natural history of people with a Likert score on MRI of less than 3 without biopsy at long-term follow‑up?

    Recommendation ID NG131/5 Question What is the natural history of people with a Likert score on MRI of less than 3 without biopsy at long-term

    Research recommendation
    Published
    25 October 2019

  15. NICE concluded that further research directly comparing the clinical and cost effectiveness of ranibizumab and bevacizumab in people with macular oedema secondary to retinal vein occlusion should be conducted.

    Recommendation ID TA283/1 Question NICE concluded that further research directly comparing the clinical and cost effectiveness of ranibizumab

    Research recommendation
    Published
    9 June 2015